Stay updated on GLY-200 Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the GLY-200 Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the GLY-200 Safety in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedKey history and versioning sections were removed, including Study Record Versions, Record History, and Results Posted, along with related identifiers and sponsor information. Access to the study record's past changes and audit trail is now reduced.SummaryDifference9%

- Check10 days agoChange DetectedThe page history shows a new revision entry (v3.3.4) added and a previous revision (v3.3.3) removed, indicating a minor update to the history metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record history now includes a new revision entry (v3.3.3), and the footer’s HHS Vulnerability Disclosure link was removed along with the previous revision (v3.3.2). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Study Record Versions section now shows a new revision: v3.3.2, with the previous v3.3.1 no longer listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page history shows a new revision entry (v3.3.1) and removal of a prior revision (v3.2.0); no user-facing content or data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the government funding lapse notice that warned about potential delays in updating information. The page now displays only study-related content without the informational banner.SummaryDifference0.7%

Stay in the know with updates to GLY-200 Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLY-200 Safety in Type 2 Diabetes Clinical Trial page.